HSIC
54
-3
LUV
39
-5
TEL
60
2
HCP
58
4
MTB
63
-2
BMY
53
-7
T
50
3
ED
48
3
AKAM
43
3
JNJ
41
2
PSA
51
-4
IFF
53
2
ABT
57
-5
MA
55
-7
TGNA
53
2
ZBH
60
-2
HD
47
-5
AIG
38
-4
HP
38
-2
URI
53
-2
HSIC
54
-3
LUV
39
-5
TEL
60
2
HCP
58
4
MTB
63
-2
BMY
53
-7
T
50
3
ED
48
3
AKAM
43
3
JNJ
41
2
PSA
51
-4
IFF
53
2
ABT
57
-5
MA
55
-7
TGNA
53
2
ZBH
60
-2
HD
47
-5
AIG
38
-4
HP
38
-2
URI
53
-2
Financhill
Back

Thomson Reuters 10K Form

Sell
39

TRI
Thomson Reuters

Last Price:
160.68
Seasonality Move:
5.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRI News And Ratings

See the #1 stock for the next 7 days that we like better than TRI

TRI Financial Statistics

Sales & Book Value

Annual Sales: $6.79B
Cash Flow: $607M
Price / Cash Flow: 36.09
Annual Sales: $26.40
Price / Book: 6.11

Profitability

EPS (TTM): 5.08000
Net Income (TTM): $2.3B
Gross Margin: $5.5B
Return on Equity: 20.26%
Return on Assets: 12.28%

Thomson Reuters Earnings Forecast

Key Thomson Reuters Financial Ratios

  • The Gross Profit Margin over the past 29 years for TRI is 80.94%.
  • The Selling, General & Administrative Expenses for TRI have been equal to 37.28% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 8.79% of Operating Income.
  • The Net Earning history of TRI is 39.67% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 13 years.

Thomson Reuters Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Professional Services
Sector: Industrials
Current Symbol: TRI
CUSIP: 884903
Website: thomsonreuters.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 0.94
Quick Ratio: 0.74

Price-to-Earnings

Trailing P/E Ratio: 27.78
Forward P/E Ratio: 39.91

TRI Technical Analysis vs Fundamental Analysis

Sell
39
Thomson Reuters (TRI) is a Sell

Is Thomson Reuters a Buy or a Sell?

  • Thomson Reuters stock is rated a Sell
    The current Thomson Reuters [TRI] share price is $160.74. The Score for TRI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.